Reuters logo
BRIEF-Akari Therapeutics announces further clinical progress
2017年10月11日 / 上午11点28分 / 8 天前

BRIEF-Akari Therapeutics announces further clinical progress

Oct 11 (Reuters) - Akari Therapeutics PLC

* Akari Therapeutics announces further clinical progress

* Akari Therapeutics - 3 additional patients have been enrolled in ongoing Phase II Cobalt clinical trial of Coversin in patients with PNH​

* Akari Therapeutics PLC - plans to provide an update on all PNH patients currently enrolled at American Society Of Hematology on Dec 9 to 12, 2017​

* Akari Therapeutics PLC - ‍Akari plans to advance coversin towards Phase III clinical trials beginning with capstone in Q1 2018​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below